Distribution of the human leukocyte antigen class II alleles in Brazilian patients with chronic hepatitis C virus infection (Q45389812)

14 December 2017

title

Distribution of the human leukocyte antigen class II alleles in Brazilian patients with chronic hepatitis C virus infection (English)

1 reference

14 December 2017

1 reference

1 reference

D B Corghi

1

1 reference

14 December 2017

N S L Gonçales

series ordinal

2

1 reference

14 December 2017

S B D Marques

series ordinal

3

1 reference

14 December 2017

F L Gonçales Jr

series ordinal

4

1 reference

14 December 2017

language of work or name

English

0 references

publication date

30 September 2008

1 reference

Brazilian Journal of Medical and Biological Research

14 December 2017

published in

1 reference

14 December 2017

volume

41

1 reference

14 December 2017

issue

10

1 reference

14 December 2017

page(s)

884-889

1 reference

HLA class II genotypes associated with chronic hepatitis C virus infection and response to alpha-interferon treatment in Poland

14 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2008005000041

Genes of the major histocompatibility complex class II influence the outcome of hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2008005000041

MHC class II genes influence the susceptibility to chronic active hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2008005000041

Influence of HLA haplotypes on the clinical courses of individuals infected with hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2008005000041

HLA association with hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2008005000041

Evolution of hepatitis C virus infection under host factor influence in an ethnically complex population

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2008005000041

An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2008005000041

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2008005000041

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2008005000041

The interrelationship between hepatitis C virus and HLA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2008005000041

Racial differences in HLA class II associations with hepatitis C virus outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2008005000041

Human leukocyte antigen class II associations with hepatitis C virus clearance and virus‐specific CD4 T cell response among Caucasians and African Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2008005000041

Viral clearance in hepatitis C (1b) infection: relationship with human leukocyte antigen class II in a homogeneous population

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2008005000041

Association between HLA class II alleles and protection from or susceptibility to chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2008005000041

Decreased frequency of the HLA-DRB1*11 allele in patients with chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2008005000041

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2008005000041

Hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2008005000041

T-lymphocyte response to hepatitis C virus in different clinical courses of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2008005000041

Lack of a strong association between HLA class II, tumour necrosis factor and transporter associated with antigen processing gene polymorphisms and virological response to alpha-interferon treatment in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2008005000041

Study of the association between major histocompatibility complex class II genes and the response to interferon alpha in patients with chronic hepatitis C infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2008005000041

Interferon-alpha therapy in HCV hepatitis: HLA phenotype and cirrhosis are independent predictors of clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2008005000041

Human leukocyte antigen class I and II alleles and response to interferon-alpha treatment, in Taiwanese patients with chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2008005000041

Association between MHC Class II Alleles and Clearance of Circulating Hepatitis C Virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2008005000041

T-cell response to structural and nonstructural hepatitis C virus antigens in persistent and self-limited hepatitis C virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2008005000041

10.1590/S0100-879X2008005000041

21 January 2018

Identifiers

DOI

1 reference

14 December 2017

1 reference